Literature DB >> 30082481

NanR Regulates Sporulation and Enterotoxin Production by Clostridium perfringens Type F Strain F4969.

Eric Mi1, Jihong Li1, Bruce A McClane2.   

Abstract

Clostridium perfringens type F strains, which produce C. perfringens enterotoxin (CPE), are a major cause of gastrointestinal infections, including the second most prevalent bacterial foodborne illness and 5 to 10% cases of antibiotic-associated diarrhea. Virulence of type F strains is primarily ascribable to CPE, which is synthesized only during sporulation. Many type F strains also produce NanI sialidase and carry a nan operon that likely facilitates uptake and metabolism of sialic acid liberated from glycoconjugates by NanI. During vegetative growth of type F strain F4969, NanR can regulate expression of nanI Given their importance for type F disease, the current study investigated whether NanR can also influence sporulation and CPE production when F4969 or isogenic derivatives are cultured in modified Duncan-Strong sporulation (MDS) medium. An isogenic F4969 nanR null mutant displayed much less sporulation and CPE production but more NanI production than wild-type F4969, indicating that NanR positively regulates sporulation and CPE production but represses NanI production in MDS. Results for the nanR mutant also demonstrated that NanR regulates expression of the nan operon. A nanI nanR double null mutant mirrored the outcome of the nanR null mutant strain but with a stronger inhibition of sporulation and CPE production, even after overnight incubation. Coupled with results using a nanI null mutant, which had no impairment of sporulation or CPE production, NanR appears to carefully modulate the availability of NanI, nan operon-encoded proteins and sialic acid to provide sufficient nutrients to sustain sporulation and CPE production when F4969 is cultured in MDS medium.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  C. perfringens; Clostridium perfringens; NanI; NanR; enterotoxin; sialidase; sporulation

Mesh:

Substances:

Year:  2018        PMID: 30082481      PMCID: PMC6204728          DOI: 10.1128/IAI.00416-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Evaluating the involvement of alternative sigma factors SigF and SigG in Clostridium perfringens sporulation and enterotoxin synthesis.

Authors:  Jihong Li; Bruce A McClane
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  NanI Sialidase Can Support the Growth and Survival of Clostridium perfringens Strain F4969 in the Presence of Sialyated Host Macromolecules (Mucin) or Caco-2 Cells.

Authors:  Jihong Li; Bruce A McClane
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

3.  Phenotypic characterization of enterotoxigenic Clostridium perfringens isolates from non-foodborne human gastrointestinal diseases.

Authors:  R E Collie; J F Kokai-Kun; B A McClane
Journal:  Anaerobe       Date:  1998-04       Impact factor: 3.331

4.  NanR Regulates nanI Sialidase Expression by Clostridium perfringens F4969, a Human Enteropathogenic Strain.

Authors:  Jihong Li; Daniel R Evans; John C Freedman; Bruce A McClane
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

5.  Inorganic phosphate induces spore morphogenesis and enterotoxin production in the intestinal pathogen Clostridium perfringens.

Authors:  Valeria A Philippe; Marcelo B Méndez; I-Hsiu Huang; Lelia M Orsaria; Mahfuzur R Sarker; Roberto R Grau
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 6.  Host sialoglycans and bacterial sialidases: a mucosal perspective.

Authors:  Amanda L Lewis; Warren G Lewis
Journal:  Cell Microbiol       Date:  2012-05-23       Impact factor: 3.715

7.  Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model.

Authors:  Sameera Sayeed; Francisco A Uzal; Derek J Fisher; Juliann Saputo; Jorge E Vidal; Yue Chen; Phalguni Gupta; Julian I Rood; Bruce A McClane
Journal:  Mol Microbiol       Date:  2008-01       Impact factor: 3.501

8.  Influence of starch source on sporulation and enterotoxin production by Clostridium perfringens type A.

Authors:  R Labbe; E Somers; C Duncan
Journal:  Appl Environ Microbiol       Date:  1976-03       Impact factor: 4.792

Review 9.  Toxin plasmids of Clostridium perfringens.

Authors:  Jihong Li; Vicki Adams; Trudi L Bannam; Kazuaki Miyamoto; Jorge P Garcia; Francisco A Uzal; Julian I Rood; Bruce A McClane
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 10.  Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Applications.

Authors:  John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Toxins (Basel)       Date:  2016-03-16       Impact factor: 4.546

View more
  5 in total

Review 1.  Sialidases From Clostridium perfringens and Their Inhibitors.

Authors:  Yan-Hua Wang
Journal:  Front Cell Infect Microbiol       Date:  2020-01-10       Impact factor: 5.293

2.  Pathogenicity and virulence of Clostridium perfringens.

Authors:  Iman Mehdizadeh Gohari; Mauricio A Navarro; Jihong Li; Archana Shrestha; Francisco Uzal; Bruce A McClane
Journal:  Virulence       Date:  2021-12       Impact factor: 5.428

3.  NanH Is Produced by Sporulating Cultures of Clostridium perfringens Type F Food Poisoning Strains and Enhances the Cytotoxicity of C. perfringens Enterotoxin.

Authors:  Jihong Li; Bruce A McClane
Journal:  mSphere       Date:  2021-04-28       Impact factor: 4.389

4.  Spo0A Suppresses sin Locus Expression in Clostridioides difficile.

Authors:  Babita Adhikari Dhungel; Revathi Govind
Journal:  mSphere       Date:  2020-11-04       Impact factor: 4.389

Review 5.  Role of Clostridium perfringens Necrotic Enteritis B-like Toxin in Disease Pathogenesis.

Authors:  Kyung-Woo Lee; Hyun S Lillehoj
Journal:  Vaccines (Basel)       Date:  2021-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.